Delivery Order SPE2DR25D1106-SPE2DR26FJP9K
Award Date 3/2/26
Potential Completion Date 3/3/26
Potential Value $4.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $3,383.04 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Moxifloxacin 400 mg (30-count), with an ultimate completion date of March 6, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, a $999,999,999 vehicle through December 2026 that supplies pharmaceutical products and medical supplies to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order is firm...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count packages) with a contract ceiling value of $1,188.24. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by September 15, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for moxifloxacin HCL 400 mg tablets (30-count), with a ceiling value of $1,198.16.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 26, 2026. No set-aside was used.</p>
- <p>The Defense Logistics Agency issued a $11,557.40 delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for moxifloxacin HCL 400 mg tablets, UD 50s, with an ultimate completion date of March 6, 2026.</p> <p>The order is issued under a firm fixed-price structure with no set-aside. Place of performance is Conshohocken, PA. The order carries no set-aside designation and was competitively awarded.</p>
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Moxifloxacin HCl 400 mg tablets in unit dose packages of 50 units. This contract, valued at $6,900, utilizes firm fixed pricing with an ultimate completion date of August 11, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $2,516.25 to AmerisourceBergen Drug Corp for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 units. This firm fixed-price contract, awarded on January 28, 2026, with an ultimate completion date of January 29, 2026, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin HCl 400 mg tablets (unit dose, 50s) with a ceiling value of $1,380.00. This competitive, non-set-aside contract was awarded on July 31, 2025, with a completion date of August 1, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, under firm fixed-price terms as a delivery order, indicating this is a fulfillment against an...
- <p>The Defense Logistics Agency issued a $30,304.88 delivery order to Amerisourcebergen Drug Corp on February 22, 2026, for moxifloxacin HCL 400 mg tablets (UD 50s).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 23, 2026. No set-aside was used.</p>
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Moxifloxacin HCl 400 mg tablets (30-count packaging) with a ceiling value of $1,596.49. This firm fixed-price delivery order is set to be completed by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without set-aside designation through competitive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 30, 2026, for Moxifloxacin HCL 400 mg tablets (30-count packages) with a ceiling value of $1,490.60 and an ultimate completion date of February 2, 2026. This firm fixed-price contract was competitively awarded without any set-aside designation, demonstrating the contractor's ability to meet federal procurement...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJP9KDelivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for moxifloxacin HCL 400 mg tablets (30-count) with a ceiling value of $4,228.80, under firm fixed-price terms. The order was issued under the Defense Logistics Agency Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that supplies pharmaceutical products and medical commodities to support military healthcare programs worldwide. Place of performance is Conshohocken, Pennsylvania. The ultimate completion date is March 3, 2026. No set-aside was used in this award.
Generated 5/31/26, 9:58 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 3/1/26 |